H.R. 1359 · 118th Congress (2023–2025)
Modernizing Opioid Treatment Access Act
This bill expands access to methadone for an individual's unsupervised use to treat opioid use disorder (OUD). (Typically, methadone must be dispensed to individuals in person through opioid treatment programs.)
The bill (1) waives provisions of the Controlled Substances Act that require qualified practitioners to obtain a separate registration from the Drug Enforcement Administration (DEA) to prescribe and dispense methadone to treat OUD, and (2) requires the Substance Abuse and Mental Health Services Administration and the DEA to jointly report on the waiver.
Additionally, the bill directs the DEA to register certain practitioners to prescribe methadone that is dispensed through a pharmacy for an individual's unsupervised use. Qualified practitioners must be licensed or authorized to prescribe controlled substances, and they must either work for an opioid treatment program or be a physician or psychiatrist with a specialty certification in addiction medicine. A state may request that the DEA stop registering such practitioners in its jurisdiction.
Individuals who receive methadone for unsupervised use must continue to have access to other care through an opioid treatment program.
For purposes of the waiver, the bill also requires the exclusive use of electronic prescribing, establishes prescription limits, and sets out requirements for informed consent. Further, the bill permits the use of telehealth to provide methadone treatment and related services if the state and the Department of Health and Human Services jointly determine the use is feasible and appropriate.
Show official title
To expand the take-home prescribing of methadone through pharmacies.
Expired in House committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to Health
This bill’s path
This is H.R. 1359’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
Expired
- Sponsor
- Rep. Donald Norcross (D-NJ-1)
- Cosponsors
70 cosponsors
7 original · 63 later
6 R · 64 D
- Rep. Don Bacon (R-NE-2)· Original · Mar 3, 2023
- Rep. Brian K. Fitzpatrick (R-PA-1)· Original · Mar 3, 2023
- Rep. Ann M. Kuster (D-NH-2)· Original · Mar 3, 2023
- Rep. Andy Kim (D-NJ-3)· Original · Mar 3, 2023
- Rep. Brittany Pettersen (D-CO-7)· Original · Mar 3, 2023
- Rep. Paul Tonko (D-NY-20)· Original · Mar 3, 2023
- Rep. David J. Trone (D-MD-6)· Original · Mar 3, 2023
- Rep. Brian Higgins (D-NY-26)· Later · Mar 7, 2023
- Rep. Marie Gluesenkamp Perez (D-WA-3)· Later · Mar 10, 2023
- Rep. Jared Huffman (D-CA-2)· Later · Mar 14, 2023
- Rep. Chrissy Houlahan (D-PA-6)· Later · Mar 14, 2023
- Rep. Juan Vargas (D-CA-52)· Later · Mar 14, 2023
- Rep. Daniel T. Kildee (D-MI-8)· Later · Mar 27, 2023
- Rep. Angie Craig (D-MN-2)· Later · Mar 28, 2023
- Rep. Jasmine Crockett (D-TX-30)· Later · Apr 3, 2023
- Rep. Colin Z. Allred (D-TX-32)· Later · Apr 13, 2023
- Rep. Nikki Budzinski (D-IL-13)· Later · Apr 13, 2023
- Rep. Josh Harder (D-CA-9)· Later · Apr 13, 2023
- Rep. Lori Trahan (D-MA-3)· Later · Apr 13, 2023
- Rep. Donald G. Davis (D-NC-1)· Later · Apr 19, 2023
- Rep. Jake Auchincloss (D-MA-4)· Later · Apr 25, 2023
- Rep. Brendan F. Boyle (D-PA-2)· Later · May 10, 2023
- Rep. J. Luis Correa (D-CA-46)· Later · May 10, 2023
- Rep. Lauren Underwood (D-IL-14)· Later · May 18, 2023
- Rep. Becca Balint (D-VT)· Later · Sep 18, 2023
- Rep. Mark DeSaulnier (D-CA-10)· Later · Sep 28, 2023
- Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Oct 26, 2023
- Rep. Susan Wild (D-PA-7)· Later · Nov 1, 2023
- Rep. Zoe Lofgren (D-CA-18)· Later · Nov 2, 2023
- Rep. Bonnie Watson Coleman (D-NJ-12)· Later · Nov 13, 2023
- Del. Eleanor Holmes Norton (D-DC)· Later · Nov 14, 2023
- Rep. Mike Quigley (D-IL-5)· Later · Dec 5, 2023
- Rep. Mike Levin (D-CA-49)· Later · Dec 6, 2023
- Rep. Suzan K. DelBene (D-WA-1)· Later · Dec 12, 2023
- Rep. Josh Gottheimer (D-NJ-5)· Later · Dec 12, 2023
- Rep. Kevin Mullin (D-CA-15)· Later · Dec 12, 2023
- Rep. Frank J. Mrvan (D-IN-1)· Later · Jan 3, 2024
- Rep. Jimmy Panetta (D-CA-19)· Later · Jan 11, 2024
- Rep. Dean Phillips (D-MN-3)· Later · Jan 11, 2024
- Rep. Suzanne Bonamici (D-OR-1)· Later · Jan 29, 2024
- Rep. Christopher R. Deluzio (D-PA-17)· Later · Jan 29, 2024
- Rep. Adriano Espaillat (D-NY-13)· Later · Jan 29, 2024
- Rep. Rick Larsen (D-WA-2)· Later · Jan 29, 2024
- Rep. Yvette D. Clarke (D-NY-9)· Later · Feb 6, 2024
- Rep. Derek Kilmer (D-WA-6)· Later · Feb 6, 2024
- Rep. James P. McGovern (D-MA-2)· Later · Feb 28, 2024
- Rep. Debbie Wasserman Schultz (D-FL-25)· Later · Mar 5, 2024
- Rep. Michael Lawler (R-NY-17)· Later · Mar 7, 2024
- Rep. Bradley Scott Schneider (D-IL-10)· Later · Mar 8, 2024
- Rep. Steven Horsford (D-NV-4)· Later · Mar 11, 2024
- Rep. Robin L. Kelly (D-IL-2)· Later · Mar 12, 2024
- Rep. Ayanna Pressley (D-MA-7)· Later · Mar 13, 2024
- Rep. Ed Case (D-HI-1)· Later · Mar 29, 2024
- Rep. Chellie Pingree (D-ME-1)· Later · Apr 5, 2024
- Rep. Elissa Slotkin (D-MI-7)· Later · May 7, 2024
- Rep. Debbie Dingell (D-MI-6)· Later · May 8, 2024
- Rep. Melanie A. Stansbury (D-NM-1)· Later · May 21, 2024
- Rep. Sheila Jackson Lee (D-TX-18)· Later · May 31, 2024
- Rep. Andrea Salinas (D-OR-6)· Later · Jun 26, 2024
- Rep. Jim Costa (D-CA-21)· Later · Jul 2, 2024
- Rep. Daniel S. Goldman (D-NY-10)· Later · Jul 2, 2024
- Rep. Mary Sattler Peltola (D-AK)· Later · Jul 8, 2024
- Rep. Shri Thanedar (D-MI-13)· Later · Jul 11, 2024
- Rep. Rashida Tlaib (D-MI-12)· Later · Jul 22, 2024
- Rep. Anthony D'Esposito (R-NY-4)· Later · Aug 6, 2024
- Rep. Delia C. Ramirez (D-IL-3)· Later · Aug 6, 2024
- Rep. Ami Bera (D-CA-6)· Later · Sep 24, 2024
- Res. Comm. Jenniffer González-Colón (R-PR)· Later · Oct 11, 2024
- Rep. Brandon Williams (R-NY-22)· Later · Oct 11, 2024
- Rep. Ritchie Torres (D-NY-15)· Later · Oct 29, 2024
- Policy area
- Health
- Subjects
- Congressional oversight
- Drug therapy
- Drug, alcohol, tobacco use
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Mar 3, 2023 – Mar 10, 2023
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Expired
Introduced → Referred to House Health → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Modernizing Opioid Treatment Access Act
Display title, Short title · Introduced in House
To expand the take-home prescribing of methadone through pharmacies.
Official title · Introduced in House